Influence of physician networks on prescribing a new ingredient combination in heart failure: a longitudinal claim data-based study.

ABSTRACT:

Background

Since 2016, the combination of sacubitril/valsartan, which combines an angiotensin receptor and neprilysin inhibitor (ARNI), has been recommended in the guidelines for the treatment of heart failure. The adoption of new drugs may be influenced by collaboration and exchange between physicians. We aimed to determine whether characteristics of the professional networks of prescribing physicians were associated with the prescribing of ARNI in Germany.

Methods

We conducted a longitudinal analysis based on claims data in 2016-2018 in Germany. The characteristics of ambulatory care physicians' networks were determined in the analysis of the patient-sharing networks of physicians in 2017. Binary logistic regression analysis with the outcome 'prescribes ARNI in 2018' (pres

SUBMITTER: Arnold C 

PROVIDER: S-EPMC8401102 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature